Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

India expands use of controversial drug for coronavirus despite safety concerns

Top medical agency says its studies show hydroxychloroquine can prevent infection, but regulators in other countries are investigating adverse effects.
  1. Priyanka Pulla
    View author publications

    You can also search for this author in PubMed  Google Scholar

UPDATE: On 4 June, a study reporting that hydroxychloroquine is dangerous to people with COVID-19, referenced in this article1, was retracted. See 'High-profile coronavirus retractions raise concerns about data oversight'.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-020-01619-8

Updates & Corrections

  • Update 05 June 2020: This article was updated to note the retraction of a study suggesting that hydroxychloroquine might be dangerous to patients with COVID-19.

References

  1. Mehra, M. R., Desai, S. S., Ruschitzka, F. & Patel, A. N. Lancet https://doi.org/10.1016/S0140-6736(20)31180-6 (2020).

    Article  Google Scholar 

  2. Chatterjee, P. et al. Indian J. Med. Res. https://doi.org/10.4103/ijmr.IJMR_2234_20 (2020).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links